Compare AXP & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AXP | TMO |
|---|---|---|
| Founded | 1850 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.1B | 216.4B |
| IPO Year | N/A | N/A |
| Metric | AXP | TMO |
|---|---|---|
| Price | $380.20 | $570.86 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 22 | 20 |
| Target Price | $327.57 | ★ $630.42 |
| AVG Volume (30 Days) | ★ 2.5M | 1.6M |
| Earning Date | 01-23-2026 | 01-29-2026 |
| Dividend Yield | ★ 0.86% | 0.30% |
| EPS Growth | ★ 9.59 | 8.54 |
| EPS | 14.88 | ★ 17.32 |
| Revenue | ★ $65,294,000,000.00 | $43,736,000,000.00 |
| Revenue This Year | $19.83 | $4.33 |
| Revenue Next Year | $8.85 | $4.94 |
| P/E Ratio | ★ $25.72 | $33.05 |
| Revenue Growth | ★ 10.22 | 3.22 |
| 52 Week Low | $220.43 | $385.46 |
| 52 Week High | $387.49 | $610.97 |
| Indicator | AXP | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 65.30 | 49.13 |
| Support Level | $360.70 | $561.91 |
| Resistance Level | $374.88 | $579.08 |
| Average True Range (ATR) | 7.43 | 10.97 |
| MACD | 1.82 | -2.81 |
| Stochastic Oscillator | 85.26 | 26.08 |
American Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. It operates in four segments: US consumer services, US commercial services, international card services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).